Related Experiment Video
Updated: Jan 2, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Relationship Between Cannabis Use and Erectile Dysfunction: A Systematic Review and Meta-Analysis
Damiano Pizzol1, Jacopo Demurtas2, Brendon Stubbs3,4,5
1Italian Agency for Development Cooperation, Jerusalem, Israel.
Cannabis use is linked to a higher risk of erectile dysfunction (ED). This review found ED prevalence was 69.1% in cannabis users versus 34.7% in non-users, suggesting a significant association.
Area of Science:
- Urology
- Andrology
- Pharmacology
Background:
- Global cannabis use and legalization are increasing.
- Cannabis has potential therapeutic effects but also undefined health risks.
- Erectile dysfunction (ED) is a common male sexual disorder with potential links to cannabis use.
Purpose of the Study:
- To systematically review and summarize the prevalence and risk of ED in cannabis users compared to non-users.
- To collate existing literature on the association between cannabis consumption and ED.
Main Methods:
- Systematic review of major databases (inception to January 1, 2019).
- Inclusion of five case-control studies with data from 3,395 men (1,035 cannabis users, 2,360 controls).
- Random-effect model used to calculate odds ratio (OR) and 95% confidence intervals (CI) for ED.
Main Results:
- Overall ED prevalence was 69.1% in cannabis users versus 34.7% in controls.
- Cannabis users had nearly four times the odds of ED compared to controls (OR = 3.83; 95% CI: 1.30-11.28; p = .02).
- High heterogeneity (I² = 90%) was noted, with prediction intervals overlapping 1.00.
Conclusions:
- Data suggest ED is approximately twice as high in cannabis users compared to controls.
- Further longitudinal research is required to confirm these findings.
- Future studies should explore a potential dose-response relationship between cannabis and ED.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

